[Intravenous immunoglobulins in chronic idiopathic myositis]

Z Rheumatol. 2005 Mar;64(2):102-10. doi: 10.1007/s00393-005-0695-7.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Chronic Disease
  • Clinical Trials as Topic
  • Contraindications
  • Dermatomyositis / drug therapy*
  • Dermatomyositis / immunology
  • Humans
  • Immunization, Passive* / adverse effects
  • Immunoglobulin G / administration & dosage*
  • Immunoglobulin G / adverse effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Infusions, Intravenous
  • Middle Aged
  • Myositis, Inclusion Body / drug therapy*
  • Myositis, Inclusion Body / immunology
  • Polymyositis / drug therapy*
  • Polymyositis / immunology
  • Treatment Outcome

Substances

  • IgG, sulfonated
  • Immunoglobulin G
  • Immunosuppressive Agents